From Eliot Forster, Executive Chair of MedCity
With April marking the first anniversary of MedCity’s launch, this is a good time to look both backwards and forward. I am amazed that we are only one year old, given the progress and achievements we have made whilst to a large extent having been in ‘set up’ mode. This first year of achievement is a huge tribute to the energy and drive of our Chief Operating Officer Sarah Haywood and her team, as well as to the support we have received from our life sciences sector partners and, most notably our Advisory Board. My thanks go out to you all.
This year has seen the continued progress of our life sciences economy, with record investment into the sector, new players in the MedCity region, in particular from the US, and a plethora of new businesses. I anticipate continued progress in the coming year, especially as we see the emergence of integrated life sciences opportunities where data, applications, medical need and new therapies combine to provide the innovation patients are waiting for.
We will be holding an event to mark the first anniversary of MedCity later this year and I will be able to share more details with you shortly. Together we will continue to advance our ambitions to grow the region’s life sciences economy.